Worldwide Healthcare Trust plc (WWH) ORD GBP0.025
Sell:328.50p
Buy:329.50p
0
Change:
2.00p
(0.61%)
2.00p
(0.61%)
FTSE 250:1.23%
Market closed |
Prices as at close on 22 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- Create an alert
- This stock can be held in a
Sell:328.50p
Buy:329.50p
Change:
2.00p
(0.61%)
2.00p
(0.61%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Market closed |
Prices as at close on 22 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Sell:328.50p
Buy:329.50p
Change:
2.00p
(0.61%)
2.00p
(0.61%)
Market closed |
Prices as at close on 22 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Objective
In order to achieve a high level of capital growth, the Company invests in the global healthcare sector and in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. It uses gearing, and derivative transactions to mitigate risk and also to enhance returns.
| Security | Weight |
|---|---|
| Eli Lilly and Co | 8.94% |
| AstraZeneca plc Ordinary US$0.25 | 7.29% |
| Boston Scientific Corp | 7.19% |
| Intuitive Surgical Inc | 6.54% |
| Novo Nordisk DKK0.1 B | 6.43% |
| Merck & Co Inc | 4.81% |
| Daiichi Sankyo Co Ltd | 4.80% |
| Tenet Healthcare Corp | 4.65% |
| Biogen Inc | 4.38% |
| UnitedHealth Group Inc | 3.89% |
| Sector | Weight |
|---|---|
| Healthcare | 97.24% |
| Country | Weight |
|---|---|
| United States | 72.62% |
| United Kingdom | 7.29% |
| Japan | 7.11% |
| Denmark | 6.43% |
| China | 3.14% |
| Hong Kong | 0.64% |
Fee Structure
The Investment Manager receives a fee equal to 0.65% p.a. of the NAV of Company. The performance fee amounts to 15% of any outperformance of the NAV over the benchmark index. The Company may be terminated by either party giving notice of not less than 12 months.
Dividend Policy
It is the policy to pay out dividends to shareholders at least to the extent required to maintain investment trust status for each financial year. Such dividends will typically be paid twice a year by means of an interim dividend and a final dividend.
ASSET SPLIT
Trust Manager
Not currently available for this investment trust.
Manager Bio
Not currently available for this investment trust.
Board Of Directors
Doug McCutcheonChairman, Sven Borho, Sian Hansen, William Hemmings, Joanne Parfrey, Timothy Livett, Bandhana Rawal
Data policy - All information should be used for indicative purposes only. You should
independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete,
and accepts no responsibility for how it may be used.
Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.